Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Potential Anti-Thrombotic Effect without Accompanying Hemorrhage with Fostamatinib Use in Patients with Immune Thrombocytopenia

Ivy Altomare, MD, Vadim V. Markovtsov, PhD, Leslie Todd, Dheepika Weerasinghe, PhD, Robert P. Numerof, PhD, Sandy Tong, MD, Esteban Masuda, PhD, James B. Bussel, MD

Blood (2019) 134 (Supplement_1): 4889.

https://doi.org/10.1182/blood-2019-126558

Published: 2019

Journal Articles

Comorbidities Such As Thromboembolic Events Significantly Worsen Patient-Reported Quality of Life (QoL) and Symptoms in Myeloproliferative Neoplasms (MPN) - Data from the Bioregistry of the German Study Group for MPN (GSG-MPN)

Blood (2018) 132 (Supplement 1): 4292.

https://doi.org/10.1182/blood-2018-99-112377

Published: 2018

Journal Articles

The Yield of Echocardiography in the Diagnosis of Infective Endocarditis in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

Ghazi S. Alotaibi, Irwindeep Sandhu, MD FRCPC, Joseph M. Brandwein, MD FRCPC, Lalit Saini, MD

Blood (2018) 132 (Supplement 1): 5177.

https://doi.org/10.1182/blood-2018-99-120018

Published: 2018

Journal Articles

Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis

Matteo Rota, Paolo A Cortesi, Roberto Crea, DVM, MSc, Alessandro Gringeri, MD PhD, Lorenzo G Mantovani

Blood (2017) 130 (Supplement 1): 1077.

https://doi.org/10.1182/blood.V130.Suppl_1.1077.1077

Published: 2017

Journal Articles

Hepatobiliary and Thromboembolic Events during Long-Term E.X.T.E.N.Ded Treatment with Eltrombopag in Adult Patients with Chronic Immune Thrombocytopenia (ITP)

Mansoor N. Saleh, James B Bussel, MD, Raymond SM Wong, Balkis Meddeb, Abdulgabar Salama, Ali El-Ali, Erhard Quebe-Fehling, PhD, Abderrahim Khelif

Blood (2016) 128 (22): 1368.

https://doi.org/10.1182/blood.V128.22.1368.1368

Published: 2016

Journal Articles

The First Case of Primary Cardiac Lymphoma, Diffuse Large B-Cell Type, Successfully Treated with EPOCH-R

Sherise Chantell Rogers, MD MPH, Owen A. O'Connor, MD PhD, Glen Granati, MD, Kavitha Yaddanapudi, MD

Blood (2016) 128 (22): 5418.

https://doi.org/10.1182/blood.V128.22.5418.5418

Published: 2016

Journal Articles

Four Decade Cumulative Review of Thrombo-Embolic Events Reported with the Use of Activated Prothrombin Complex Concentrate in Congenital Haemophilia

Roberto Crea, DVM, MSc, Aaron Novack, Armin J Reininger, Justine Kennedy, Sandra Raff, Alessandro Gringeri, MD MSc, Naghmana Bajwa

Blood (2016) 128 (22): 5031.

https://doi.org/10.1182/blood.V128.22.5031.5031

Published: 2016

Journal Articles

Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy

Eric M. Ammann, Michael P. Jones, Brian K. Link, Ryan M. Carnahan, Scott K. Winiecki, James C. Torner, Bradley D. McDowell, Bruce H. Fireman, Elizabeth A. Chrischilles

Blood (2016) 127 (2): 200–207.

https://doi.org/10.1182/blood-2015-05-647552

Published: 2016

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Pegylated Interferon Alpha-2a in Patients with Essential Thrombocythemia and Polycythemia Vera: Results after a Median 7-Year Follow-up of a Phase 2 Study

Lucia Masarova, MD, Srdan Verstovsek, MD, Keyur P. Patel, MD PhD, Kate J Newberry, PhD, Jorge E. Cortes, MD, Gautam Borthakur, MD, Marina Konopleva, MD PhD, Zeev Estrov, MD, Hagop M. Kantarjian, MD

Blood (2015) 126 (23): 60.

https://doi.org/10.1182/blood.V126.23.60.60

Published: 2015

Journal Articles

A Single Center Retrospective Analysis of Outcomes Following the Use of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Real-Life Settings

Ranjit Joseph, MD, Amanda Strickland, James Burner, MD, Sean Yates, MD, William Tharpe, PharmD, Ravindra Sarode, MD

Blood (2014) 124 (21): 1561.

https://doi.org/10.1182/blood.V124.21.1561.1561

Published: 2014

Journal Articles

Update On The Safety and Efficacy Of EXTENDed Treatment With Eltrombopag (EPAG) In Adults With Chronic Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Mansoor N. Saleh, MD, Raymond S.M. Wong, Paul Burgess, Kalpana Bakshi, BS, MS, Geoffrey W. Chan, MD, Christine K. Bailey, PhD

Blood (2013) 122 (21): 2315.

https://doi.org/10.1182/blood.V122.21.2315.2315

Published: 2013

Journal Articles

Baseline Laboratory Parameters Potentially Associated with Thrombophilia in Patients with Chronic ITP.

Raymond S.M. Wong, Kalpana Bakshi, BS, MS, Andres Brainsky, MD

Blood (2012) 120 (21): 2191.

https://doi.org/10.1182/blood.V120.21.2191.2191

Published: 2012

Journal Articles

Thrombin Generation Responses to Human Factor XIa in Plasma of Animal Species

Yideng Liang, MD, Evi B Struble, PhD, Li Ma, Samuel A Woodle, Naveen Jha, PhD, Dorothy Scott, MD, Timothy K Lee, PhD, Mikhail V Ovanesov, PhD

Blood (2012) 120 (21): 5142.

https://doi.org/10.1182/blood.V120.21.5142.5142

Published: 2012

Journal Articles

Long-Term Safety and Efficacy of Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP): Report of up to 5.5 Years of Treatment in EXTEND.

Mansoor N Saleh, MD, Gregory Cheng, James B Bussel, MD, Paul Burgess, Kalpana Bakshi, BS, MS, Andres Brainsky, MD, Christine K Bailey, PhD

Blood (2012) 120 (21): 2198.

https://doi.org/10.1182/blood.V120.21.2198.2198

Published: 2012

Journal Articles

The Improved Efficacy of Bortezomib Containing Induction Regimens (BCIR) Versus Non-Bortezomib Containing Induction Regimens (NBCIR) in Transplant-Eligible Patients with Multiple Myeloma (MM): Meta-Analysis of Phase III Randomized Controlled Trials (RCTs),

Ajay K. Nooka, MD, MPH, FACP, Jonathan L. Kaufman, MD, Madhusmita Behera, Charise Gleason, Amelia Langston, MD, Conor Ermst Steuer, MD, Christopher R Flowers, MD, Lawrence H. Boise, PhD, Sagar Lonial, MD

Blood (2011) 118 (21): 3994.

https://doi.org/10.1182/blood.V118.21.3994.3994

Published: 2011

Journal Articles

Safety and Efficacy of Extended Treatment with Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2011,

Mansoor N Saleh, MD, Gregory Cheng, MD, PhD, James B Bussel, MD, Paul Burgess, Lisa Marcello, BA, MS, Christine K Bailey, PhD, Andres Brainsky, MD

Blood (2011) 118 (21): 3296.

https://doi.org/10.1182/blood.V118.21.3296.3296

Published: 2011

Journal Articles

Thalidomide As Maintenance Therapy in Multiple Myeloma (MM) Improves Progression Free Survival (PFS) and Overall Survival (OS): A Meta-Analysis

Ajay K. Nooka, MD, MPH, FACP, Madhusmita Behera, Lawrence H. Boise, PhD, Melanie Watson, Jonathan L. Kaufman, MD, Sagar Lonial, MD

Blood (2011) 118 (21): 1855.

https://doi.org/10.1182/blood.V118.21.1855.1855

Published: 2011

Journal Articles

Ischemic Stroke in Young Patients with Cardiac Abnormalities and Hypercoagulable State: 2 Case Reports and Literature Review to Assess Diagnostic and Prevention Options

Lisa Thomas, MD, Qi Shi, MD, Arjinder Sethi, MD, Sathyanarayanan Ramakrishnan, MD, Jihua Jia, MD, Linda Thomas-Hemak, MD

Blood (2011) 118 (21): 4663.

https://doi.org/10.1182/blood.V118.21.4663.4663

Published: 2011

Journal Articles

EXTEND Study Update: Safety and Efficacy of Eltrombopag In Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2010

Mansoor N. Saleh, MD, Gregory Cheng, MD, PhD, James B. Bussel, MD, Huiping Sun, Bhabita Mayer, MSc, Christine Bailey, PhD, Andres Brainsky, MD

Blood (2010) 116 (21): 67.

https://doi.org/10.1182/blood.V116.21.67.67

Published: 2010

Journal Articles

Incidence of Thromboembolic Events Across Eltrombopag Clinical Trials In Chronic Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Gregory Cheng, MD, PhD, Mansoor N. Saleh, MD, Bhabita Mayer, MSc, Sandra Y. Vasey, MS, Andres Brainsky, MD

Blood (2010) 116 (21): 70.

https://doi.org/10.1182/blood.V116.21.70.70

Published: 2010

NARROW

Potential Anti-Thrombotic Effect without Accompanying Hemorrhage with Fostamatinib Use in Patients with Immune Thrombocytopenia

Comorbidities Such As Thromboembolic Events Significantly Worsen Patient-Reported Quality of Life (QoL) and Symptoms in Myeloproliferative Neoplasms (MPN) - Data from the Bioregistry of the German Study Group for MPN (GSG-MPN)

The Yield of Echocardiography in the Diagnosis of Infective Endocarditis in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis

Hepatobiliary and Thromboembolic Events during Long-Term E.X.T.E.N.Ded Treatment with Eltrombopag in Adult Patients with Chronic Immune Thrombocytopenia (ITP)

The First Case of Primary Cardiac Lymphoma, Diffuse Large B-Cell Type, Successfully Treated with EPOCH-R

Four Decade Cumulative Review of Thrombo-Embolic Events Reported with the Use of Activated Prothrombin Complex Concentrate in Congenital Haemophilia

Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy

Efficacy and Safety of Pegylated Interferon Alpha-2a in Patients with Essential Thrombocythemia and Polycythemia Vera: Results after a Median 7-Year Follow-up of a Phase 2 Study

A Single Center Retrospective Analysis of Outcomes Following the Use of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Real-Life Settings

Update On The Safety and Efficacy Of EXTENDed Treatment With Eltrombopag (EPAG) In Adults With Chronic Immune Thrombocytopenia (ITP)

Baseline Laboratory Parameters Potentially Associated with Thrombophilia in Patients with Chronic ITP.

Thrombin Generation Responses to Human Factor XIa in Plasma of Animal Species

Long-Term Safety and Efficacy of Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP): Report of up to 5.5 Years of Treatment in EXTEND.

The Improved Efficacy of Bortezomib Containing Induction Regimens (BCIR) Versus Non-Bortezomib Containing Induction Regimens (NBCIR) in Transplant-Eligible Patients with Multiple Myeloma (MM): Meta-Analysis of Phase III Randomized Controlled Trials (RCTs),

Safety and Efficacy of Extended Treatment with Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2011,

Thalidomide As Maintenance Therapy in Multiple Myeloma (MM) Improves Progression Free Survival (PFS) and Overall Survival (OS): A Meta-Analysis

Ischemic Stroke in Young Patients with Cardiac Abnormalities and Hypercoagulable State: 2 Case Reports and Literature Review to Assess Diagnostic and Prevention Options

EXTEND Study Update: Safety and Efficacy of Eltrombopag In Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2010

Incidence of Thromboembolic Events Across Eltrombopag Clinical Trials In Chronic Immune Thrombocytopenia (ITP)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only